Rufinamide
NDC 69452-223, Rufinamide, suspension, from Bionpharma Inc..
- Product NDC
- 69452-223
- Status
- Listed
- Labeler
- Bionpharma Inc.
- Dosage form
- SUSPENSION
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA211388
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/69452-223 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- RUFINAMIDE40 mg/mL
| Package NDC | NDC-11 | Package |
|---|---|---|
| 69452-223-84 | 69452022384 | 1 BOTTLE in 1 CARTON (69452-223-84) / 460 mL in 1 BOTTLE |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/e2ba061a-49f0-4330-b0f0-00f2c3725625NADAC price for package 69452022384
GET /v1/drugs/nadac/69452022384
Use it
Look up 69452-223 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/69452-223 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 69452-223. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.